Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

Q: Paragraph: CES is allowing space for sex tech companies as a one-year trial. At the show, such companies were scattered throughout the health and wellness section, near startups pitching fitness trackers and infrared saunas. Lora DiCarlo, a startup that pushed for changes after organizers revoked its award, showed off its Osé robotic “personal massager.” It’s one of a dozen companies at the show focused on vibrators, lube dispensers and other sex tech products. Founders of these startups say their products are about empowerment and wellness for women, something they say has often been overlooked in tech. The historically male-dominated tech trade show has received criticism in past years for having an all-male lineup of speakers and for previously allowing scantily clad “booth babes,” fostering a “boys’ club” reputation. Besides allowing sex tech, CES organizers brought in an official “equality partner,” The Female Quotient, to help ensure gender diversity. The Female Quotient, which trains companies in equality practices, will hold a conference for women during the four-day show, which opened Tuesday. “It’s been a process,” said Gary Shapiro, the head of the Consumer Technology Association, which puts on CES. It’s been a longer process for many sex tech companies to convince investors that they are part of a growing trend that has enough customers. Much of the push has come from the startups’ female founders and from younger consumers who talk more openly about sexuality. As with other technologies, some exhibitors including Lora DiCarlo had prominent booths at CES, while others such as the wearable vibrator company Crave were tucked away. Crave’s exhibit included a camper with a “Build-a-Vibe-Workshop,” where attendees could get an engraved vibrator to wear around their neck. Sex tech has existed in some form for decades. But the gates really began to open in 2016, said Andrea Barrica, founder of sex education site O.school. That year, several other “fem tech” companies made progress in areas such as menstruation and menopause. Those paved the way for sex tech to grow and get investors interested. “Larger institutions are starting to take note, all the way from VC firms to large Fortune 100 companies,” said Barrica, who recently published the book “Sextech Revolution: The Future of Sexual Wellness.” Large institutions like CES had no choice but to look at sex tech, she said. The journey hasn’t been easy. Sex tech founders, many of them women, recount being turned down by dozens of investors. They faced decency arguments and entrenched corporate standards that equated them with porn. But investors are becoming more receptive, said Cindy Gallop, a former advertising executive turned sex tech entrepreneur and founder of the website MakeLoveNotPorn. “It’s entirely because of our refusal to allow the business world to put us down,” she said. Founders insist that their devices — ranging from vibrators to lube dispensers to accessories — have effects outside the bedroom. “Sexual health and wellness is health and wellness,” said Lora DiCarlo, CEO and founder of the company of the same name. “It does way more than just pleasure. It’s immediately connected to stress relief, to better sleep, to empowerment and confidence.” DiCarlo’s $290 Osé device has gotten $3 million worth of advance sales, bolstered in part by the attention it received after CES organizers overturned a decision by an independent panel of judges to give the vibrator a prestigious Innovation Honoree Award in the robotics and drone category. The organizers, CTA, told the company it reserved the right to rescind awards for devices deemed “immoral, obscene, indecent, profane or not in keeping with CTA’s image.” DiCarlo and other female founders pushed back for banning them but allowing humanoid sex robots meant to serve men the previous year. Following criticism, CES organizers ultimately  reinstated the award and apologized. A few months later, the show announced policy changes such as a dress code to prevent skimpy outfits and new “Innovation for All” sessions with senior diversity officials. Osé began shipping to customers this month. DiCarlo said the company is planning to introduce new devices, including less expensive options. Sex tech companies still face major barriers to growth. Polly Rodriguez, CEO of sexual wellness company Unbound, said the company is profitable and customers are more open about buying products than they once were. But she said she still faces roadblocks advertising on social media, and many traditional investors snub the company. “Things are better, but there’s just still this genuine fear of female sexuality more broadly within the institutional side of technology,” she said. And while Gallop offered to speak at CES, conference organizers declined, saying sex tech was not a part of its conference programming. ___ AP Business Writer Joseph Pisani contributed to this report. ___ AP’s CES coverage: https://apnews.com/Consumerelectronics Claim: Sex tech from women-led startups pops up at CES gadget show.

A: 2
****
Q: Paragraph: Many of China’s usually teeming cities have almost become ghost towns during the past two weeks as Communist Party rulers ordered virtual lockdowns, canceled flights, closed factories and shut schools. Even on Monday, a large number of workplaces and schools will remain closed and many white-collar employees will work from home. The scale of the potential hit to an economy that has been the engine of global growth in recent years has taken a toll on financial markets, as shares slumped and investors switched into safe-havens such as gold, bonds and the Japanese yen. China’s ambassador to Britain described the newly identified virus as “the enemy of mankind” in a BBC interview on Sunday, but added it “is controllable, is preventable, is curable”. “At this moment is very difficult to predict when we are going to have an inflection point,” Liu Xiaoming said. “We certainly hope it will come soon, but the isolation and quarantine measures have been very effective.”  China’s cabinet said it would coordinate with transport authorities to ensure the smooth return to work of employees in key industries such as food and medicines. The State Council’s special coronavirus group also said workers should return in “batches”, rather than all at once, in order to reduce infection risks. China’s National Health Commission recorded another 89 deaths on Saturday, pushing the total well above the 774 who died from SARS, or Severe Acute Respiratory Syndrome in 2002/2003. GRAPHIC: Comparing new coronavirus to SARS and MERS - here  Total confirmed coronavirus cases in China stood at 37,198, commission data showed. New infections recorded the first drop below 3,000 cases Feb. 2, at 2,656 cases. Of those, 2,147 cases were in Hubei province, the epicenter of the outbreak. The virus has also spread to at least 27 countries and territories, according to a Reuters count based on official reports, infecting more than 330 people. Two deaths have been reported outside mainland China - both of Chinese nationals. The latest patients outside China include a group of British nationals staying in a mountain village in Haute-Savoie in the Alps, French health officials said, raising fears of further infections at a busy period in the ski season. A British man who contracted the virus while attending a conference in Singapore may have infected seven other people when he stopped off at a chalet in the French village on his way home, health experts said. Those infected include a British man diagnosed in Spain and a Briton found to have the disease in the UK, both of whom appeared to have been part of the chalet group. GRAPHIC: Tracking the novel coronavirus - here  As millions of Chinese prepared to go back to work, the public dismay and mistrust of official numbers was evident on Weibo, China’s equivalent of Twitter. “What’s even more frustrating is that these are only the ‘official’ data,” said one user. “We all know we can’t purchase masks anywhere, why are we still going back to work?” said a second. “More than 20,000 doctors and nurses around the country have been sent to Hubei, but why are the numbers still rising?” asked a third. Authorities had told businesses to tack up to 10 extra days on to holidays that had been due to finish at the end of January and some restrictions continued. Gaming giant Tencent Holdings said it had asked staff to continue working from home until Feb. 21. Hebei province, which surrounds Beijing, will keep schools shut until March 1, the People’s Daily newspaper said. Several provinces have shut schools until the end of February. The local government in the southern manufacturing hub of Shenzhen, meanwhile, denied a report in the Nikkei business daily that it had blocked a plan by Apple supplier Foxconn Technology Co to resume production in China from Monday. The company would restart once inspections were completed, it said. Among the latest deaths, 81 were in Hubei. An American hospitalized in the provincial capital Wuhan, where the outbreak began, became the first confirmed non-Chinese victim. Joseph Eisenberg, professor of epidemiology at the School of Public Health at the University of Michigan, said it was too early to say whether the epidemic was peaking. “Even if reported cases might be peaking, we don’t know what is happening with unreported cases,” he said. Major cities and capitals announced new travel restrictions as concern over the spread of the virus increased. Chinese-ruled Hong Kong introduced a two-week quarantine on Saturday for all people arriving from the mainland, or who have been there during the previous 14 days. Malaysia expanded its ban on visitors from China. France issued a new travel advisory for its citizens, saying it did not recommend traveling to China unless there was an “imperative” reason. Italy asked children traveling from China to stay away from school for two weeks voluntarily. Princess Cruises, operator of the Diamond Princess cruise ship quarantined off Japan, said a further six people had tested positive, bringing the total cases aboard to 70. (This story corrects to remove in paragraph 23 reference to 53-year-old geneticist who died, citing Washington Post, after newspaper said it incorrectly identified the name and age of a U.S. citizen who died.) Claim: 'Enemy of mankind': Coronavirus deaths top SARS as China returns to work.

A: 2
****
Q: Paragraph: A price range of $200,000 to $250,000 for the device was included in the story. However, there was no mention of physician fees or hospital stay costs. The longest a patient has lived with device was included in the story, but no range was given for the length of time patients survived with the device for reference. While putting a premium on the “one more Christmas, one more birthday” concept, there was no discussion about the differences in quality of life experienced by the patients receiving the device. Only the results from the longest living recipient of the device were included in the article. For balance, it would have been useful to include the average amount of time that people survived with the device as well as some mention of consequences of the treatment that may affect quality of life. Further, it is hard to predict who will live “less than a month.” It is possible that some recipients may have their life shortened (death in surgery or immediately thereafter). The article mentions that the evidence about the device comes from only 14 patients to date who have had it implanted. No overt disease-mongering, although the story contained no information on the prevelance of heart failure or the percentage of individuals with heart failure for whom this treatment might be considered. The article contained quotes from physicians directly involved in the clinical trial leading to the humanitarian device exemption, family members of patients who had, on balance, positive experiences with the device and the director of the FDA division responsible for the decision. The article would have been improved had it contained the views of some individuals slightly more removed from the device itself to help provide a framework in which to consider the ramifications of this treatment. While mentioning that this device is only for patients with advanced heart failure who have no other options and would otherwise die, the story just three sentences later quotes a surgeon stating that the device’s approval “gives tons of hope to people with end-stage heart failure”. This paints a somewhat unrealistic picture about the limited group of patients for whom the device is an option. In addition to only being intended for those who are not eligible for a heart transplant and who would likely live less than a month without the device, it is only for patients whose chest is large enough to hold the device. Although the story didn’t explain that the device was only approved by the FDA using the “Humanitarian Device Exemption,” it did say that sales of only up to 4,000/yr would be allowed and that it is much more likely that far fewer will be sold. The story also explained that the device will be available at only 5 institutions in the U.S. It is valuable for readers to understand the limited availability of this device for appropriate expectations. The story was clear that only 14 people have received this medical device. The article does not appear to rely exclusively on a press release. However, the quotes attributed to Dr. Daniel Schultz, director of the FDA’s Center for Devices and Radiological Health came from the FDA news release on the device, found at http://www.fda.gov/bbs/topics/NEWS/2006/NEW01443.html. Claim: FDA approves AbioCor heart

A:
1
****